ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Iowa » Internal Medicine

Top Internal Medicine Prescribers in Iowa

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DOMINICK ERVELLI D.O.

Internal Medicine

8,420

$318K

273
254 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

8%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$38
Average prescription price

Avg: $50

MARK LIABOE M.D.

Internal Medicine

8,400

$319K

406
365 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

10%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 24%

$38
Average prescription price

Avg: $50

THOMAS BAINBRIDGE M.D.

Internal Medicine

8,333

$397K

225
173 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

17%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $50

PETER REITER MD

Internal Medicine

8,318

$379K

507
413 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

15%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$46
Average prescription price

Avg: $50

HILLARD SALAS M.D.

Internal Medicine

8,304

$407K

359
285 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $50

MARK COLLISON M.D.

Internal Medicine

8,298

$481K

502
459 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 24%

$58
Average prescription price

Avg: $50

DIANE HEINDL MD

Internal Medicine

8,281

$449K

355
308 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $50

DALE VANDER BROEK DO

Internal Medicine

8,162

$362K

430
389 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$44
Average prescription price

Avg: $50

DAVID RATHE DO

Internal Medicine

8,149

$298K

387
354 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

6%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$37
Average prescription price

Avg: $50

STEVEN ERICKSON MD

Internal Medicine

8,115

$477K

366
340 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

9%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$59
Average prescription price

Avg: $50

ANGELA KELLEY D.O.

Internal Medicine

8,095

$370K

364
287 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

15%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$46
Average prescription price

Avg: $50

DAVID SMITH DO

Internal Medicine

8,039

$416K

354
285 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

15%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$52
Average prescription price

Avg: $50

BRENDA BURROUGH MD

Internal Medicine

8,035

$426K

455
406 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

7%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$53
Average prescription price

Avg: $50

CHRISTINE SINSKY M.D.

Internal Medicine

7,963

$341K

385
348 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

7%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$43
Average prescription price

Avg: $50

TODD JENSEN M.D.

Internal Medicine

7,914

$407K

281
250 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$51
Average prescription price

Avg: $50

KAREN SPAHR DO

Internal Medicine

7,893

$286K

306
250 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

9%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 24%

$36
Average prescription price

Avg: $50

TODD BERRYHILL M.D.

Internal Medicine

7,857

$512K

446
411 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

8%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$65
Average prescription price

Avg: $50

WILLIAM JEROME MD

Internal Medicine

7,839

$458K

302
279 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

10%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 24%

$58
Average prescription price

Avg: $50

VINKO BOGDANIC M.D.

Internal Medicine

7,783

$448K

331
268 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

18%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$58
Average prescription price

Avg: $50

ARUL MOLIAN M.D.

Internal Medicine

7,757

$423K

466
403 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$55
Average prescription price

Avg: $50

THOMAS SNYDER DO

Internal Medicine

7,755

$359K

311
241 are 65+

14%
patients receiving schedule two controlled substances

Avg: 5%

19%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$46
Average prescription price

Avg: $50

STEWART KANIS DO

Internal Medicine

7,746

$501K

356
311 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

12%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$65
Average prescription price

Avg: $50

VICTORIA KOGAN MD

Internal Medicine

7,741

$317K

496
403 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

10%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$41
Average prescription price

Avg: $50

ROBERT FLOYD D.O.

Internal Medicine

7,697

$575K

304
246 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$75
Average prescription price

Avg: $50

WILLIAM RIESEN MD

Internal Medicine

7,683

$368K

437
375 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $50

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank